Walleye Capital
TLSIW icon

Walleye Capital’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Walleye Capital’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-80,883
Closed -$147K – 5868
2024
Q2 		$147K Hold
80,883
– – ﹤0.01% 4504
2024
Q1 		$80.9K Buy
80,883
+3,840
+5% +$3.83K ﹤0.01% 4496
2023
Q4 		$91.7K Sell
77,043
-27,554
-26% -$12.2K ﹤0.01% 4075
2023
Q3 		$39.7K Hold
104,597
– – ﹤0.01% 4254
2023
Q2 		$4.38K Hold
104,597
– – ﹤0.01% 4046
2023
Q1 		$6.42K Sell
104,597
-1,100
-1% -$97 ﹤0.01% 3609
2022
Q4 		$7.93K Hold
105,697
– – ﹤0.01% 2794
2022
Q3 		$6K Hold
105,697
– – ﹤0.01% 2901
2022
Q2 		$9K Hold
105,697
– – ﹤0.01% 2031
2022
Q1 		$27K Buy
105,697
+488
+0.5% +$210 ﹤0.01% 1908
2021
Q4 		$55K Buy
+105,209
New +$96.6K ﹤0.01% 1766

Other funds holding TLSIW

VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.75B AUM 18.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Walleye Capital's TLSIW Position: Q3 2024 in Review

Walleye Capital sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2024, closing a stake of 80,883 shares — an estimated $147K sold.

Walleye Capital first reported a position in TLSIW in Q4 2021 and held it in 11 quarters. The position peaked at $147K in Q2 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q3 2024.

  • Walleye Capital reported no remaining TriSalus Life Sciences Warrant position as of Q3 2024 after selling out during the quarter.
  • Walleye Capital sold 80,883 TriSalus Life Sciences Warrant shares in Q3 2024, an estimated $147K.
  • Walleye Capital first reported a position in TriSalus Life Sciences Warrant in Q4 2021 and held it in 11 quarters.
  • Walleye Capital's TriSalus Life Sciences Warrant position peaked at $147K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2024.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.